Ahmed, M.E.; Alzahrani, K.K.; Fahmy, N.M.; Almutairi, H.H.; Almansour, Z.H.; Alam, M.W.
Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer. Pharmaceutics 2025, 17, 556.
https://doi.org/10.3390/pharmaceutics17050556
AMA Style
Ahmed ME, Alzahrani KK, Fahmy NM, Almutairi HH, Almansour ZH, Alam MW.
Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer. Pharmaceutics. 2025; 17(5):556.
https://doi.org/10.3390/pharmaceutics17050556
Chicago/Turabian Style
Ahmed, Mais E., Kholoud K. Alzahrani, Nedal M. Fahmy, Hayfa Habes Almutairi, Zainab H. Almansour, and Mir Waqas Alam.
2025. "Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer" Pharmaceutics 17, no. 5: 556.
https://doi.org/10.3390/pharmaceutics17050556
APA Style
Ahmed, M. E., Alzahrani, K. K., Fahmy, N. M., Almutairi, H. H., Almansour, Z. H., & Alam, M. W.
(2025). Colistin-Conjugated Selenium Nanoparticles: A Dual-Action Strategy Against Drug-Resistant Infections and Cancer. Pharmaceutics, 17(5), 556.
https://doi.org/10.3390/pharmaceutics17050556